NorthWest Biotherapeutics Inc (NWBO)

[trocprofit]

My takeaway is that there is confidence there. I don't believe there is ambiguous data results. I think all of the steps they are taking is simply to get to the point of presenting the irrefutable. Even so, I believe they think it's still a David vs. Goliath situation, thus the delays to try to get it perfect. Concurrent efforts in steps is another. What may have started as linear is now happening simultaneously. In other words, I think final review by SAB, Experts, peer-review for Journal, are happening at once. They want PR/TLD and Journal will be very close together, as they've said. The sticking point is Journal timing. The "business decision" to go solo with TLD before Journal acceptance or publication date (in line with desired TLD) could be in play but it clearly doesn't sound like the first choice. Would love to see it all play out before year's end, but no gut on that.